Clinical Trial Update: A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating GRF6021 for improving postoperative recovery after hip or knee arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Recovery

Drugs mentioned

• GRF6021

Snippet

Sponsor: Alkahest, Inc. | Conditions: Postoperative Recovery | Phase 2 | Status: COMPLETED | Results posted: 2024-03-13